These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 9402107)

  • 1. Lack of effect of different cytokines on expression of membrane-bound regulators of complement activity on human uveal melanoma cells.
    Blom DJ; Goslings WR; De Waard-Siebinga I; Luyten GP; Claas FH; Gorter A; Jager MJ
    J Interferon Cytokine Res; 1997 Nov; 17(11):695-700. PubMed ID: 9402107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.
    Goslings WR; Blom DJ; de Waard-Siebinga I; van Beelen E; Claas FH; Jager MJ; Gorter A
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1884-91. PubMed ID: 8759358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokines modulate expression of cell-membrane complement inhibitory proteins in human lung cancer cell lines.
    Varsano S; Rashkovsky L; Shapiro H; Radnay J
    Am J Respir Cell Mol Biol; 1998 Sep; 19(3):522-9. PubMed ID: 9730881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
    Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M
    Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
    Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ
    Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-mediated modulation of integrin, ICAM-1 and CD44 expression on human uveal melanoma cells in vitro.
    Creyghton WM; de Waard-Siebinga I; Danen EH; Luyten GP; van Muijen GN; Jager MJ
    Melanoma Res; 1995 Aug; 5(4):235-42. PubMed ID: 7496158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costimulatory molecule expression on human uveal melanoma cells: functional analysis of CD40 and B7-H1.
    Ma J; Usui Y; Kezuka T; Okunuki Y; Zhang L; An X; Mizota A; Goto H
    Exp Eye Res; 2012 Mar; 96(1):98-106. PubMed ID: 22200489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decitabine up-regulates S100A2 expression and synergizes with IFN-gamma to kill uveal melanoma cells.
    Gollob JA; Sciambi CJ
    Clin Cancer Res; 2007 Sep; 13(17):5219-25. PubMed ID: 17785578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of epidermal growth factor receptor in the metastasis of intraocular melanomas.
    Ma D; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1067-75. PubMed ID: 9620065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy.
    López MN; Pereda C; Ramírez M; Mendoza-Naranjo A; Serrano A; Ferreira A; Poblete R; Kalergis AM; Kiessling R; Salazar-Onfray F
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1219-27. PubMed ID: 17325166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.
    Moutabarrik A; Nakanishi I; Namiki M; Hara T; Matsumoto M; Ishibashi M; Okuyama A; Zaid D; Seya T
    Lymphokine Cytokine Res; 1993 Jun; 12(3):167-72. PubMed ID: 7688580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokines affect resistance of human renal tumour cells to complement-mediated injury.
    Blok VT; Gelderman KA; Tijsma OH; Daha MR; Gorter A
    Scand J Immunol; 2003 Jun; 57(6):591-9. PubMed ID: 12791098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD55 limits sensitivity to complement-dependent cytolysis triggered by heterologous expression of α-gal xenoantigen in colon tumor cells.
    Wu Y; Wang Y; Qin F; Wang Z; Wang Y; Yang Y; Zheng H; Wang Y
    Am J Physiol Gastrointest Liver Physiol; 2014 Jun; 306(12):G1056-64. PubMed ID: 24763553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of 12 cytokines in aqueous humour of uveal melanoma before and after combined Ruthenium-106 brachytherapy and transpupillary thermotherapy.
    Lee CS; Jun IH; Kim TI; Byeon SH; Koh HJ; Lee SC
    Acta Ophthalmol; 2012 Jun; 90(4):e314-20. PubMed ID: 22429778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relation between c-myc expression and interferon sensitivity in uveal melanoma.
    Tulley PN; Neale M; Jackson D; Chana JS; Grover R; Cree I; Grobbelaar AO; Wilson GD
    Br J Ophthalmol; 2004 Dec; 88(12):1563-7. PubMed ID: 15548813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and possible function of IL-2 and IL-15 receptors on human uveal melanoma cells.
    He YG; Mayhew E; Mellon J; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4240-6. PubMed ID: 15557426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-mediated up-regulation of CD55 and CD59 protects human hepatoma cells from complement attack.
    Spiller OB; Criado-García O; Rodríguez De Córdoba S; Morgan BP
    Clin Exp Immunol; 2000 Aug; 121(2):234-41. PubMed ID: 10931136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uveal melanoma expresses NK-1 receptors and cyclosporin A induces apoptosis in human melanoma cell lines overexpressing the NK-1 receptor.
    González-Ortega A; Sánchez-Vaderrábanos E; Ramiro-Fuentes S; Salinas-Martín MV; Carranza A; Coveñas R; Muñoz M
    Peptides; 2014 May; 55():1-12. PubMed ID: 24548567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary human hepatocytes are protected against complement by multiple regulators.
    Halme J; Sachse M; Vogel H; Giese T; Klar E; Kirschfink M
    Mol Immunol; 2009 Jul; 46(11-12):2284-9. PubMed ID: 19446335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating cytokines in patients with metastatic cancer treated with recombinant interleukin 2 and lymphokine-activated killer cells.
    Gemlo BT; Palladino MA; Jaffe HS; Espevik TP; Rayner AA
    Cancer Res; 1988 Oct; 48(20):5864-7. PubMed ID: 3139285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.